(n=46)
Age (years), mean ± SD 72 ± 9
Height (cm), mean ± SD 171 ± 9
Weight (kg), mean ± SD 77 ± 16
BSA (m²), mean ± SD 1.9 ± 0.2
Sex
Male, n (%) 34 (74%)
Female, n (%) 12 (26%)
Race
White, n (%) 44 (96%)
COPD, n (%) 2 (4%)
Creatinine (µmol/L), mean ± SD 130 ± 59
eGFR (mL/min), mean ± SD 53 ± 20
NT-proBNP (ng/L), mean ± SD 3447 ± 3148
Heart rate (bpm), mean ± SD 74 ± 13
Cardiovascular history
Atrial fibrillation 38 (83%)
NYHA class 3-4 46 (100%)
Hypertension 32 (70%)
Coronary artery disease 33 (72%)
MR mechanism
Primary, n (%) 4 (9%)
Secondary/functional, n (%) 42 (91%)
Medications
ACE inhibitors, n (%) 30 (65%)
Beta-blockers, n (%) 34 (74%)
Digoxin, n (%) 5 (11%)
Diuretics, n (%) 41 (89%)
MRA, n (%) 26 (57%)
ARNI, n (%) 1 (2%)
CRT, n (%) 7 (15%)
Function
STS-PROM, mean ± SD 11 ± 8
6MWT, mean ± SD 284 ± 138